Merck Kgaa ADR (MKKGY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,405,354 | 758,904 | 3,067,238 | 2,444,546 | 1,642,142 |
| Depreciation Amortization | 1,221,205 | 492,908 | 2,034,724 | 1,494,373 | 1,022,795 |
| Accounts receivable | -187,381 | -69,485 | -8,658 | -54,420 | -111,221 |
| Accounts payable and accrued liabilities | -105,536 | -78,170 | -46,539 | 81,630 | 276,962 |
| Other Working Capital | -562,142 | -112,913 | -765,186 | -762,968 | -915,936 |
| Other Operating Activity | 270,302 | 132,455 | -186,156 | -230,741 | -306,402 |
| Operating Cash Flow | $2,041,802 | $1,123,699 | $4,095,423 | $2,972,420 | $1,608,340 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -885,212 | -555,878 | -1,935,152 | -1,390,975 | -932,292 |
| Net Acquisitions | N/A | N/A | -12,988 | -9,796 | N/A |
| Purchase Of Investment | N/A | -94,456 | -581,195 | -101,221 | -37,074 |
| Sale Of Investment | N/A | 376,738 | 551,973 | 472,366 | 291,137 |
| Purchase Sale Intangibles | -296,148 | -262,739 | -86,584 | -9,796 | 21,808 |
| Other Investing Activity | 110,921 | -474,451 | -70,350 | -538,758 | -511,397 |
| Investing Cash Flow | $-774,291 | $-748,047 | $-2,047,712 | $-1,568,384 | $-1,189,626 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 764,599 | N/A | 561,714 | 758,615 | N/A |
| Debt Repayment | -951,980 | -59,714 | -1,176,460 | -316,724 | 770,913 |
| Dividend Paid | -315,532 | -56,456 | -1,259,797 | -1,265,809 | -1,267,045 |
| Other Financing Activity | 0 | 0 | -1 | -1,089 | -1,090 |
| Financing Cash Flow | $-502,912 | $-116,170 | $-1,874,544 | $-825,007 | $-497,222 |
| Exchange Rate Effect | -7,538 | -2,171 | -33,551 | -20,680 | -22,898 |
| Beginning Cash Position | 2,134,416 | 2,151,857 | 2,006,584 | 2,017,894 | 2,021,602 |
| End Cash Position | 2,891,477 | 2,410,254 | 2,145,119 | 2,574,066 | 1,920,194 |
| Net Cash Flow | $757,061 | $258,397 | $138,534 | $556,172 | $-101,407 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,041,802 | 1,123,699 | 4,095,423 | 2,972,420 | 1,608,340 |
| Capital Expenditure | -903,519 | -567,821 | -1,955,716 | -1,410,566 | -946,467 |
| Free Cash Flow | 1,138,283 | 555,878 | 2,139,707 | 1,561,854 | 661,873 |